314 related articles for article (PubMed ID: 27343096)
1. Implications of Oxygen Homeostasis for Tumor Biology and Treatment.
Garvalov BK; Acker T
Adv Exp Med Biol; 2016; 903():169-85. PubMed ID: 27343096
[TBL] [Abstract][Full Text] [Related]
2. Cellular oxygen sensing need in CNS function: physiological and pathological implications.
Acker T; Acker H
J Exp Biol; 2004 Aug; 207(Pt 18):3171-88. PubMed ID: 15299039
[TBL] [Abstract][Full Text] [Related]
3. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
4. Tumor and its microenvironment: a synergistic interplay.
Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
[TBL] [Abstract][Full Text] [Related]
5. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
Araos J; Sleeman JP; Garvalov BK
Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer.
Akanji MA; Rotimi D; Adeyemi OS
Oxid Med Cell Longev; 2019; 2019():8547846. PubMed ID: 31485300
[TBL] [Abstract][Full Text] [Related]
8. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
9. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
[TBL] [Abstract][Full Text] [Related]
10. HIF-1 in cell cycle regulation, apoptosis, and tumor progression.
Goda N; Dozier SJ; Johnson RS
Antioxid Redox Signal; 2003 Aug; 5(4):467-73. PubMed ID: 13678535
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
12. Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells.
Kim KK; Abelman S; Yano N; Ribeiro JR; Singh RK; Tipping M; Moore RG
Sci Rep; 2015 Oct; 5():14296. PubMed ID: 26469226
[TBL] [Abstract][Full Text] [Related]
13. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology.
Acker T; Plate KH
J Mol Med (Berl); 2002 Sep; 80(9):562-75. PubMed ID: 12226738
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor (HIF) in human tumorigenesis.
Mabjeesh NJ; Amir S
Histol Histopathol; 2007 May; 22(5):559-72. PubMed ID: 17330811
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of adaptive angiogenesis to tissue hypoxia.
Fong GH
Angiogenesis; 2008; 11(2):121-40. PubMed ID: 18327686
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic regulation of metastasis via hypoxia-inducible factors.
Gort EH; Groot AJ; van der Wall E; van Diest PJ; Vooijs MA
Curr Mol Med; 2008 Feb; 8(1):60-7. PubMed ID: 18289014
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
Bacon AL; Harris AL
Ann Med; 2004; 36(7):530-9. PubMed ID: 15513303
[TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.
Prabhu V; Guruvayoorappan C
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):568-75. PubMed ID: 21226555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
